About Ostex International
Ostex International is a Healthcare company based in Seattle (United States) founded in 2003, and was acquired by Abbott in September 2002. The company was acqui-hired. Its focus areas include Life Sciences, Orthopedics, Drugs and Osteoporosis. Its competitors include Rani Therapeutics, Tarsa Therapeutics and Zosano Pharma; 3 of its 3 listed competitors have raised funding.
Company details
Developer of products for the management of osteoporosis. The companys products include creatinine measuring devices, bone resorption testing devices, urine testing equipment, and other related products.
- Investors
- Acquired byAbbott
(Sep 2002)
Investors in Ostex International
Ostex International has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Rapid diagnostics products and solutions for point-of-care testing are provided. | 1900 | globalpointofcare.abbott | Waukegan, United States |
Investor details for Ostex International
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ostex International
2 dated milestones of Ostex International across 1 years, from founding to its latest funding, stage changes and deals.
- Exit Acquired by Abbott.
- Founded Ostex International is founded.
Competitors of Ostex International
Ostex International has 3 listed competitors in our database, 3 of them funded. They include Rani Therapeutics, Tarsa Therapeutics and Zosano Pharma.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ranitherapeutics.com | 2012 | San Jose, United States | $226.49M | Technology for oral delivery of large drug molecules is developed. | ||
| tarsatherapeutics.com | 2009 | Philadelphia, United States | $76.69M | 2 | Oral treatments for postmenopausal osteoporosis are developed. | |
| zosanopharma.com | 2006 | Fremont, United States | $147.16M | 40 | Develops innovative transdermal drug delivery technologies for various therapeutic applications. |
Detailed competitors of Ostex International
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as Ostex International (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ostex International
Ostex International was founded in 2003.
Ostex International is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Developer of products for the management of osteoporosis. The companys products include creatinine measuring devices, bone resorption testing devices, urine testing equipment, and other related products.
Ostex International's top competitors include Rani Therapeutics, Tarsa Therapeutics and Zosano Pharma.
Ostex International has 1 investor. Key investors include Abbott Global Point of Care.
Yes. Ostex International was acquired by Abbott in September 2002.